{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:49:38Z","timestamp":1788263378870,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.cca.2020.07.037","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T20:49:09Z","timestamp":1595450949000},"page":"400-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Autoantibodies against specific nuclear antigens are present in psoriatic disease and are diminished by secukinumab"],"prefix":"10.1016","volume":"510","author":[{"given":"Eleni","family":"Patrikiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Liaskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Mavropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Ntavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4775-0410","authenticated-orcid":false,"given":"Athanasios","family":"Gkoutzourelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Simopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2344-3854","authenticated-orcid":false,"given":"Thomas","family":"Scheper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8973-4550","authenticated-orcid":false,"given":"Wolfgang","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina G.","family":"Katsiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggeliki","family":"Roussaki-Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efterpi","family":"Zafiriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaros I.","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9997","key":"10.1016\/j.cca.2020.07.037_b0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.cca.2020.07.037_b0010","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cca.2020.07.037_b0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13075-018-1517-z","article-title":"E.c.-w.o.b.o.t.D.p.r.g.w.t.E. network, Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group","volume":"20","author":"Adler","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.cca.2020.07.037_b0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.autrev.2016.09.015","article-title":"Are psoriasis and psoriatic arthritis the same disease? The IL-23\/IL-17 axis data","volume":"16","author":"Sakkas","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.cca.2020.07.037_b0025","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.semarthrit.2018.10.007","article-title":"Regulatory B cells: New players in inflammatory and autoimmune rheumatic diseases","volume":"48","author":"Sakkas","year":"2019","journal-title":"Semin. Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1016\/j.cca.2020.07.037_b0030","first-page":"S61","article-title":"Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review","volume":"75","author":"Chimenti","year":"2014","journal-title":"Drug Dev. Res."},{"issue":"5","key":"10.1016\/j.cca.2020.07.037_b0035","first-page":"401","article-title":"Autoantibodies in psoriatic patients treated with anti-TNF-alpha therapy","volume":"12","author":"Bardazzi","year":"2014","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft = J. German Soc. Dermatol. JDDG"},{"issue":"4","key":"10.1016\/j.cca.2020.07.037_b0040","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2133.2009.09563.x","article-title":"Antinuclear antibodies associate with loss of response to antitumour necrosis factor-alpha therapy in psoriasis: a retrospective, observational study","volume":"162","author":"Pink","year":"2010","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.cca.2020.07.037_b0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jdermsci.2014.09.003","article-title":"Baseline anti-dsDNA concentrations and previous treatments predict response to Adalimumab and Etanercept: a retrospective investigation of 146 psoriasis patients","volume":"76","author":"Hoffmann","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.cca.2020.07.037_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00872","article-title":"Mini review: new treatment in psoriatic arhtritis, focus on the IL-17\/23 axis","volume":"10","author":"Sakkas","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.cca.2020.07.037_b0055","first-page":"543","article-title":"IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients","volume":"116","author":"Dong","year":"2003","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.cca.2020.07.037_b0060","first-page":"31","article-title":"Antinuclear antibodies in psoriatic arthritis and its subgroups","volume":"146","author":"Calzavara","year":"1989","journal-title":"Acta Derm. Venereol. Suppl."},{"issue":"5","key":"10.1016\/j.cca.2020.07.037_b0065","first-page":"661","article-title":"The formation of autoantibodies and antibodies to TNF-alpha blocking agents in relation to clinical response in patients with ankylosing spondylitis","volume":"28","author":"Arends","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5","key":"10.1016\/j.cca.2020.07.037_b0070","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2004.031286","article-title":"Autoantibodies in biological agent naive patients with psoriatic arthritis","volume":"64","author":"Johnson","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.cca.2020.07.037_b0075","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/annrheumdis-2018-214436","article-title":"Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective","volume":"78","author":"Damoiseaux","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.cca.2020.07.037_b0080","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12026-017-8974-3","article-title":"Reflex testing of speckled cytoplasmic patterns observed in routine ANA HEp-2 indirect immunofluorescence with a multiplex anti-synthetase dot-blot assay: a multicentric pilot study","volume":"66","author":"Infantino","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cca.2020.07.037_b0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clinbiochem.2018.03.020","article-title":"Evaluation of the LIA-ANA-Profile-17S for the detection of autoantibodies to nuclear antigens","volume":"55","author":"Yi","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2020.07.037_b0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fmed.2018.00088","article-title":"Recognition and relevance of anti-DFS70 autoantibodies in routine antinuclear autoantibodies testing at a community hospital","volume":"5","author":"Carter","year":"2018","journal-title":"Front. Med. (Lausanne)"},{"issue":"8","key":"10.1016\/j.cca.2020.07.037_b0095","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2020.07.037_b0100","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.3389\/fimmu.2018.02835","article-title":"Anti-Ro60 seropositivity determines anti-Ro52 epitope mapping in patients with systemic sclerosis","volume":"9","author":"Gkoutzourelas","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cca.2020.07.037_b0105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/08916934.2017.1357699","article-title":"Disease-related autoantibody profile in patients with systemic sclerosis","volume":"50","author":"Liaskos","year":"2017","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.cca.2020.07.037_b0110","first-page":"31","article-title":"Increased immunoreactivity against human cytomegalovirus UL83 in systemic sclerosis","volume":"106","author":"Marou","year":"2017","journal-title":"Clin. Exp. Rheumatol. 35 Suppl"},{"issue":"1","key":"10.1016\/j.cca.2020.07.037_b0115","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1038\/s41598-017-07801-9","article-title":"Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis","volume":"7","author":"Efthymiou","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cca.2020.07.037_b0120","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s10067-017-3553-5","article-title":"Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis","volume":"36","author":"Marou","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cca.2020.07.037_b0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2017.04.013","article-title":"IL-10-producing regulatory B cells (B10 cells), IL-17+ T cells and autoantibodies in systemic sclerosis","volume":"184","author":"Mavropoulos","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cca.2020.07.037_b0130","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kez204","article-title":"Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis","author":"Mavropoulos","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"17","key":"10.1016\/j.cca.2020.07.037_b0135","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94263","article-title":"Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis","volume":"2","author":"Stathopoulos","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.cca.2020.07.037_b0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13075-017-1231-2","article-title":"Circulating plasmablasts\/plasma cells: a potential biomarker for IgG4-related disease","volume":"19","author":"Lin","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.cca.2020.07.037_b0145","doi-asserted-by":"crossref","first-page":"R1001","DOI":"10.1186\/ar1776","article-title":"Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"7","author":"Henneken","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.cca.2020.07.037_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137195","article-title":"Circulating CXCR5(+)CD4(+) T follicular-like helper cell and memory B cell responses to human papillomavirus vaccines","volume":"10","author":"Matsui","year":"2015","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.cca.2020.07.037_b0155","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1365-2133.2011.10555.x","article-title":"Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction","volume":"165","author":"Hoffmann","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.cca.2020.07.037_b0160","first-page":"445","article-title":"Induction of autoantibodies and autoimmune diseases in patients with psoriasis receiving tumor necrosis factor inhibitors","volume":"108","author":"Oter-Lopez","year":"2017","journal-title":"Actas dermo-sifiliograficas"},{"issue":"3","key":"10.1016\/j.cca.2020.07.037_b0165","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1111\/jdv.15328","article-title":"Detailed ANA dynamics under adalimumab therapy show no significant correlation to PASI response and MTX cotreatment: a retrospective study of 98 psoriasis patients","volume":"33","author":"Hoffmann","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol"},{"issue":"2","key":"10.1016\/j.cca.2020.07.037_b0170","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/ard.2003.006775","article-title":"Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients","volume":"63","author":"Feletar","year":"2004","journal-title":"Ann. Rheumatic Dis."},{"issue":"3","key":"10.1016\/j.cca.2020.07.037_b0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1590\/S0482-50042010000300003","article-title":"Autoantibodies in patients with psoriatic arthritis on anti-TNFalpha therapy","volume":"50","author":"Viana","year":"2010","journal-title":"Revista brasileira de reumatologia"},{"issue":"2","key":"10.1016\/j.cca.2020.07.037_b0180","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10067-015-3140-6","article-title":"Infliximab-induced autoantibodies: a multicenter study","volume":"35","author":"Vaz","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"6 Pt 1","key":"10.1016\/j.cca.2020.07.037_b0185","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1067\/mai.2000.107039","article-title":"Autoantibodies to DFS 70 kd\/transcription coactivator p75 in atopic dermatitis and other conditions","volume":"105","author":"Ochs","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2020.07.037_b0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/bbrc.1999.1979","article-title":"Lens epithelium-derived growth factor: effects on growth and survival of lens epithelial cells, keratinocytes, and fibroblasts","volume":"267","author":"Singh","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.cca.2020.07.037_b0195","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/art.20095","article-title":"Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us?","volume":"50","author":"Ganapathy","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.cca.2020.07.037_b0200","first-page":"2144","article-title":"The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern","volume":"32","author":"Dellavance","year":"2005","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.cca.2020.07.037_b0205","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1128\/CVI.00386-12","article-title":"Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study","volume":"19","author":"Chioato","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.cca.2020.07.037_b0210","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3389\/fimmu.2018.01637","article-title":"T follicular helper cells in autoimmune disorders","volume":"9","author":"Gensous","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cca.2020.07.037_b0215","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/0961203314567750","article-title":"Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production","volume":"24","author":"Zhang","year":"2015","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.cca.2020.07.037_b0220","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1111\/1346-8138.14760","article-title":"Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid","volume":"46","author":"Kamata","year":"2019","journal-title":"J. Dermatol."},{"issue":"8","key":"10.1016\/j.cca.2020.07.037_b0225","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41584-019-0243-5","article-title":"Systemic effects of IL-17 in inflammatory arthritis","volume":"15","author":"Beringer","year":"2019","journal-title":"Nat. Rev. Rheumatol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120303612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120303612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:59:12Z","timestamp":1757861952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120303612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":45,"alternative-id":["S0009898120303612"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.07.037","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies against specific nuclear antigens are present in psoriatic disease and are diminished by secukinumab","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.07.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}